As we discussed last week, in Part 1 of this topic, the role of patients and physicians is changing and patients have increasing responsibility in their care. This has important implications for pharmaceutical companies, as well as for market researchers.
For pharma companies, patients are becoming a major stakeholder, whose individual needs must be considered, separately from those of physicians. This is a new way of thinking for many companies, since for years, the physicians have been seen as the conduit to and proxy for patients. Here at Aptel Research, we have seen this shift as clients are now thinking specifically about patients when creating marketing and pricing strategies, as well as in the growing availability of patient support programs.